Lumibird Competitors and Similar CompaniesClear all

Lumibird's competitors and similar companies include El.En. and IRIDEX.
Lumibird
Lumibird
Lumibird (formerly known as Quantel-Keopsys Group) is a company that designs, manufactures, and markets laser components.
El.En.
El.En.
El.En. Group is a company that provides industrial, medical, and conservation laser solutions.
IRIDEX
IRIDEX
IRIDEX is an ophthalmic medical technology company focused on the development and commercialization of products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases.
Founding Date
Founding Date
1970
Founding Date
1981
Founding Date
1989
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Lannion, FR HQ
Ottawa, CA
Shanghai, CN
Cesson Sévigné, FR
Cournon D'auvergne, FR
Le Barp, FR
Rennes, FR
see more
Locations
Calenzano, IT HQ
Blumenau, BR
Wenzhou, CN
Immendingen, DE
Jena, DE
Calenzano, IT
Calenzano, IT
see more
Locations
Mountain View, US HQ
Mannheim, DE
Employees
Employees
1,0785% increase
Employees
2,080
Employees
9316% decrease
Valuation ($)
Valuation ($)
173.4 m
Valuation ($)
920.7 m
Valuation ($)
26.8 m

Financial

Revenue (est.)
Revenue (est.)
€225.6m (FY, 2025)
Revenue (est.)
€590.8m (FY, 2025)
Revenue (est.)
$52.7m (FY, 2026)
Cost of goods
Cost of goods
€82.3m (FY, 2025)
Cost of goods
€344.9m (FY, 2025)
Cost of goods
$33.4m (FY, 2026)
Gross profit
Gross profit
€147.7m (FY, 2025)
Gross profit
€252m (FY, 2025)
Gross profit
$19.2m (FY, 2026)
Net income
Net income
€14m (FY, 2025)
Net income
€50.8m (FY, 2025)
Net income
($4.4m) (FY, 2026)

Operating

Countries
Countries
110 (FY, 2023)
Countries
15 (Aug, 2023)
Countries
N/A
For sources of this data, please see the company profile

View Company Profiles

El.En.
HQ
Calenzano, IT
Employees
2,080

El.En. Group is a company that provides industrial, medical, and conservation laser solutions.

View company
IRIDEX
HQ
Mountain View, US
Employees
93↓ 16% decrease

IRIDEX is an ophthalmic medical technology company focused on the development and commercialization of products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases.

View company